HER2-Positive Stomach Cancer: What ASCO Now Recommends

Welcome to Onco Life Centre Podcast. This episode looks at ASCO's August 2026 guideline update for HER2-positive gastric cancer, including what changed for first-line treatment and why biomarker testing now happens earlier. You'll learn: - Why ASCO updated its HER2-positive gastric cancer guideline in August 2026 - What the four newly recommended biomarker tests are - How new trial results changed first-line treatment options - What second-line options exist if first-line treatment stops wo...